Medlive Technology Statistics

Total Valuation

Medlive Technology has a market cap or net worth of HKD 7.09 billion. The enterprise value is 3.00 billion.

Market Cap	7.09B
Enterprise Value	3.00B

Important Dates

The next estimated earnings date is Monday, March 24, 2025.

Earnings Date	Mar 24, 2025
Ex-Dividend Date	Oct 22, 2024

Share Statistics

Medlive Technology has 732.88 million shares outstanding. The number of shares has increased by 0.03% in one year.

Current Share Class	n/a
Shares Outstanding	732.88M
Shares Change (YoY)	+0.03%
Shares Change (QoQ)	+1.01%
Owned by Insiders (%)	1.58%
Owned by Institutions (%)	23.11%
Float	186.21M

Valuation Ratios

The trailing PE ratio is 22.81 and the forward PE ratio is 24.02.

PE Ratio	22.81
Forward PE	24.02
PS Ratio	13.57
PB Ratio	1.40
P/TBV Ratio	1.49
P/FCF Ratio	73.03
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 25.43, with an EV/FCF ratio of 30.94.

EV / Earnings	9.62
EV / Sales	5.80
EV / EBITDA	25.43
EV / EBIT	28.15
EV / FCF	30.94

Financial Position

The company has a current ratio of 26.91, with a Debt / Equity ratio of 0.00.

Current Ratio	26.91
Quick Ratio	26.64
Debt / Equity	0.00
Debt / EBITDA	0.15
Debt / FCF	0.18
Interest Coverage	231.37

Financial Efficiency

Return on equity (ROE) is 6.46% and return on invested capital (ROIC) is 1.32%.

Return on Equity (ROE)	6.46%
Return on Assets (ROA)	1.26%
Return on Capital (ROIC)	1.32%
Revenue Per Employee	694,161
Profits Per Employee	418,135
Employee Count	742
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +35.43% in the last 52 weeks. The beta is 0.64, so Medlive Technology's price volatility has been lower than the market average.

Beta (5Y)	0.64
52-Week Price Change	+35.43%
50-Day Moving Average	9.32
200-Day Moving Average	8.22
Relative Strength Index (RSI)	49.53
Average Volume (20 Days)	1,045,340

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Medlive Technology had revenue of HKD 517.84 million and earned 311.93 million in profits. Earnings per share was 0.42.

Revenue	517.84M
Gross Profit	315.30M
Operating Income	106.65M
Pretax Income	331.61M
Net Income	311.93M
EBITDA	111.67M
EBIT	106.65M
Earnings Per Share (EPS)	0.42

Full Income Statement

Balance Sheet

The company has 4.15 billion in cash and 17.24 million in debt, giving a net cash position of 4.14 billion or 5.64 per share.

Cash & Cash Equivalents	4.15B
Total Debt	17.24M
Net Cash	4.14B
Net Cash Per Share	5.64
Equity (Book Value)	5.08B
Book Value Per Share	6.92
Working Capital	4.18B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 98.79 million and capital expenditures -1.75 million, giving a free cash flow of 97.04 million.

Operating Cash Flow	98.79M
Capital Expenditures	-1.75M
Free Cash Flow	97.04M
FCF Per Share	0.13

Full Cash Flow Statement

Margins

Gross margin is 60.89%, with operating and profit margins of 20.60% and 60.24%.

Gross Margin	60.89%
Operating Margin	20.60%
Pretax Margin	64.04%
Profit Margin	60.24%
EBITDA Margin	21.56%
EBIT Margin	20.60%
FCF Margin	18.74%

Dividends & Yields

This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 2.79%.

Dividend Per Share	0.27
Dividend Yield	2.79%
Dividend Growth (YoY)	40.95%
Years of Dividend Growth	2
Payout Ratio	74.20%
Buyback Yield	-0.03%
Shareholder Yield	2.76%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Medlive Technology has an Altman Z-Score of 15.3.

Altman Z-Score	15.3
Piotroski F-Score	n/a